Patent · US Active

Method for inhibiting Ebola virus via miRNA

US10155947B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

JIANGSU MICROMEDMARK BIOTECH CO., LTD. · CN

Inventors

Chenyu Zhang · Changsha, CN
Hongwei Liang · Plano, US
Zhen Zhou · Emeryville, US
Ke Zeng · 安丰镇, CN
Xi Chen · Beijing, CN

Key dates

Filing date	Sep 1, 2015
Grant date	Dec 18, 2018
Priority date	—
Expiry date	Sep 1, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/14121
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a method and use of microRNA MiR-2911 in regulating an ebola virus. Particularly provided are a method and use of isolated microRNA MiR-2911 in regulating an ebola virus protein gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.